| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |